StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302532% above fair value
$390.94−8.76 (-2.19%)

Close on Nov 20, 2026Market cap $44.45BP/E 69.9Yield –

BeOne Medicines Net Product Revenue by Quarter

Net Product Revenue ($M) ($M)

BeOne Medicines Net Product Revenue: $1,680M in Q2 2026, up 29.0% from a year earlier. That is the highest of the 37 quarters on record here.

Latest, Q2 2026
1,680
Period ended Jun 30, 2026
Change on a year earlier
+29.0%
1,302 in Q2 2025
History
37 quarters
Since Q2 2017
Sources
29
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Product Revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,680+29.0%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261,487+34.2%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 20251,476+32.1%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 20251,395+40.4%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20251,302+41.4%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20251,109+48.4%Form 10-Q (filed 2026-05-06) ↗
Q4 2024Dec 31, 20241,118+77.3%Form 10-K (filed 2026-02-26) ↗
Q3 2024Sep 30, 2024994+66.9%Form 10-Q (filed 2025-11-06) ↗
Q2 2024Jun 30, 2024921+66.3%Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 2024747+82.0%Form 10-Q (filed 2025-05-07) ↗
Q4 2023Dec 31, 2023631+86.0%Form 10-K (filed 2026-02-26) ↗
Q3 2023Sep 30, 2023595+70.3%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023554+81.9%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 2023410+56.8%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022339+72.3%Form 10-K (filed 2025-02-27) ↗
Q3 2022Sep 30, 2022350+81.6%Form 10-Q (filed 2023-11-09) ↗

Breakdown

What makes up net Product Revenue

Cite this data

StockData. (2026). BeOne Medicines Net Product Revenue ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev-prod-total

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?